ACUTA CAPITAL PARTNERS, LLC - RA PHARMACEUTICALS INC ownership

RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 76 filers reported holding RA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ACUTA CAPITAL PARTNERS, LLC ownership history of RA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$1,301,000
-9.3%
55,000
-79.6%
0.94%
+301.3%
Q1 2018$1,434,000
+37.4%
270,000
+277.6%
0.23%
+25.1%
Q3 2017$1,044,000
-85.1%
71,500
-80.9%
0.19%
-90.5%
Q2 2017$7,000,000
+32.6%
373,507
+50.6%
1.96%
+56.6%
Q1 2017$5,279,000
-8.0%
247,956
-34.4%
1.25%
-41.4%
Q4 2016$5,740,000377,9092.13%
Other shareholders
RA PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
NEA Management Company, LLC 6,138,797$288,094,00013.62%
RA Capital Management 4,858,260$227,998,0006.91%
HAVENS ADVISORS LLC 116,000$5,444,0004.77%
ALPINE ASSOCIATES MANAGEMENT INC. 2,115,600$99,286,0003.16%
SYQUANT CAPITAL SAS 129,690$6,086,0003.13%
BARDIN HILL MANAGEMENT PARTNERS LP 391,758$18,386,0003.02%
Kellner Capital, LLC 91,100$4,275,0002.71%
Telemetry Investments, L.L.C. 17,100$803,0002.68%
Versor Investments LP 1,002,649$47,054,0002.38%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,519,718$71,320,0002.28%
View complete list of RA PHARMACEUTICALS INC shareholders